Corvidia: Novo Nordisk moves further into CV diseases with Corvidia acquisition

Danish pharma company Novo Nordisk has entered a definitive agreement to acquire Massachusetts-headquartered Corvidia Therapeutics. The deal involves an upfront...Read More...The post Novo Nordisk moves further into CV diseases with Corvidia acquisition appeared first on Pharmaceutical Technology.